跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BORTEZOMIB TARBIS 2,5 MG/ML SOLUCIÓN INYECTABLE - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
BORTEZOMIB TARBIS 2,5 MG/ML SOLUCIÓN INYECTABLE
Approved
STANDARD
BORTEZOMIB TARBIS 2,5 MG/ML SOLUCIÓN INYECTABLE
Tarbis Farma S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 5, 2023
Approval ID
b1cc7e5468978d21
Company
Tarbis Farma S.L.
Type
Standard
Approval Details
Approval Id
b1cc7e5468978d21
Drug Cima Aemps Name
BORTEZOMIB TARBIS 2,5 MG/ML SOLUCIÓN INYECTABLE
Register Number
89182
Holder Company Name
Tarbis Farma S.L.
Marketing Company Name
Tarbis Farma S.L.
Authorization Date
2023-12-05
Dosage Form
SOLUCIÓN INYECTABLE
Dose
2,5 mg/ml
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Tarbis Farma S.L.
Active Ingredients
BORTEZOMIB
2,3827 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 5, 2023
Approval ID
b1cc7e5468978d21
Type
Standard
Back to CIMA-AEMPS Approvals
